Literature DB >> 31066229

Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinics.

David C Young1, Elizabeth Autry2,3, Jeffery T Zobell4, Lauren Kormelink2, Karen Homa5, Kathryn A Sabadosa6, Jamshed Kanga7, Michael Anstead7, Robert Kuhn2,3.   

Abstract

Cystic fibrosis (CF) is a complex genetic, multiorgan disease. The CF Foundation (CFF) recommends a multidisciplinary team (physician, nurse, respiratory therapist, dietitian, physical therapist, social worker, mental health coordinator, clinic coordinator, and pharmacist) to work with patients and families. The objective of our study was to describe the impact of a pharmacist involved in the care of patients and families from their perspective. The CF Patient and Family Experience of Care (PFEC) is a voluntary, 50-question telephonic or internet-based survey designed to continuously collect information from patients and their families regarding their care experience. From August of 2017 through February of 2018, five questions were added to the internet survey to assess the impact of the pharmacist on the care experience. From the 666 respondents, 54% reported that a pharmacist was involved in their CF care. At two CF clinics designated as "full access" to a pharmacist, respondents reported a higher percentage of the CF-team discussed medications compared to those from three clinics designated as "limited access" to the pharmacist (95% vs 67%). Respondents in clinics with "full access" to a pharmacist were significantly more likely to get their medications refilled on time (78% vs 63%) and reported using fewer pharmacies to fill their medications. Pharmacist involvement in CF care may improve patient's access to medication and the ability to sustain use.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  chronic care; cystic fibrosis; experience of care survey; multidisciplinary care; pharmacist; pharmacy care

Mesh:

Year:  2019        PMID: 31066229     DOI: 10.1002/ppul.24348

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  Using A Work System Framework to Investigate Pharmacists' Roles in Cystic Fibrosis Management.

Authors:  Olufunmilola Abraham; Megan Buechel; Sommer Gay; Lisa Szela; Catherine A Decker; Andrew T Braun
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

Review 2.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.